BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
about
Toward a Molecular Classification of Colorectal Cancer: The Role of BRAFBRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approachA further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinomaImmunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasmsOncogenic BRAF(V600E) Induces Clastogenesis and UVB HypersensitivityDNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas.Lack of BRAFV600E mutation in stage I and II of colorectal cancer.Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.Colorectal serrated pathway cancers and precursors.Microsatellite instability: an update.The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors.BRAF in metastatic colorectal cancer: the future starts now.Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations.Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry
P2860
Q26827212-B37E1740-F834-4ACD-8D4B-F9E3C58B8278Q33615076-6CA2C2DC-BF80-4338-B324-D8A9110E385DQ34052740-FEE61DA0-A546-490C-B6F3-A7E42EF6C4A1Q34084086-CC56EE3E-0604-4708-9711-4B41971368D0Q34520869-D29552DD-8586-4376-A9B9-DDC31C819CDAQ35527097-F863F7C5-EC3D-4F2D-9885-2E0603ED8096Q35818484-57F87947-4875-48C3-892C-E4D964D61614Q35878544-46E200FE-CB71-4F7D-8D57-1E9D39104166Q35995540-65ED7287-1D05-413B-AF66-E2FCDBE9C9E7Q36086848-4CE48F2E-388F-4565-95BE-A4A4529598D8Q36213262-36512B5B-4590-4829-A44B-5B495D5EC157Q38255029-425A4A5D-CCCF-4A80-BD0C-15F30C8D7E87Q38363519-6ABADDF1-6BE6-42AB-875F-18BF4FC04E92Q38481038-72A812F4-898E-4E2B-808B-ED3FE9F73DDAQ38652005-74085598-B253-43C1-9D54-FC6886A81C98Q40564690-7986BE43-CF65-456A-9BB6-4EB1620835CFQ42175718-EE0E9BAA-9480-4279-A68C-CCF8A0504D21Q46468400-4C7D10D5-A57F-450C-A4A0-168BCCD41E5BQ47614611-F4F629F6-2671-481D-B267-EA178D763426Q52659178-31E4F727-287B-43C2-95B5-005D4BA023D8Q52908238-836B83CF-0356-4FB5-94BE-84652408E03CQ54193016-ADDC062B-D0AD-433E-9337-678F886C710AQ54328227-7C7F3236-1CB2-48FC-8D12-FFB22FBA90A9Q57567361-30FBE332-591C-46FA-AFBE-D6E08552D59C
P2860
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@en
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@nl
type
label
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@en
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@nl
prefLabel
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@en
BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
@nl
P2093
P2860
P50
P1433
P1476
BRAF mutation in sporadic colorectal cancer and Lynch syndrome
@en
P2093
Alexandra Thiel
Annette Gylling
Ari Ristimäki
Arto Orpana
Jonas Kantonen
Mari Korhonen
Mira Heinonen
Soili Kytölä
P2860
P2888
P304
P356
10.1007/S00428-013-1470-9
P577
2013-08-21T00:00:00Z
P5875
P6179
1021939497